This map shows the geographic impact of F Tacconi's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by F Tacconi with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites F Tacconi more than expected).
This network shows the impact of papers produced by F Tacconi. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by F Tacconi. The network helps show where F Tacconi may publish in the future.
Co-authorship network of co-authors of F Tacconi
This figure shows the co-authorship network connecting the top 25 collaborators of F Tacconi.
A scholar is included among the top collaborators of F Tacconi based on the total number of
citations received by their joint publications. Widths of edges
represent the number of papers authors have co-authored together.
Node borders
signify the number of papers an author published with F Tacconi. F Tacconi is excluded from
the visualization to improve readability, since they are connected to all nodes in the network.
Bobbio-Pallavicini, E, Marco Confalonieri, F Tacconi, et al.. (1998). Study of release of eosinophil cationic proteins (ECP and EPX) in the hypereosinophilic syndrome (HES) and other hypereosinophilic conditions.. PubMed. 40(3). 186–90.6 indexed citations
5.
Bobbio-Pallavicini, E, L Gugliotta, Riccardo Centurioni, et al.. (1997). Antiplatelet agents in thrombotic thrombocytopenic purpura (TTP). Results of a randomized multicenter trial by the Italian Cooperative Group for TTP.. PubMed. 82(4). 429–35.84 indexed citations
6.
Bobbio-Pallavicini, E, Chiara Valsecchi, F Tacconi, Mauro Moroni, & Camillo Porta. (1995). Sarcoidosis following beta-interferon therapy for multiple myeloma. Pneumologie. 12(2). 140–142.31 indexed citations
7.
Bobbio-Pallavicini, E, et al.. (1995). Ocular involvement in acute thrombotic thrombocytopenic purpura.. PubMed. 80(2). 194–5.10 indexed citations
8.
Confalonieri, Marco, F Tacconi, Mara De Amici, et al.. (1995). Benign idiopathic hypereosinophilia: a feeble masquerader or a smouldering form of the hypereosinophilic syndrome?. PubMed. 80(1). 50–3.5 indexed citations
9.
Bobbio-Pallavicini, E, Carla Valsecchi, F Tacconi, Mauro Moroni, & Camillo Porta. (1995). Sarcoidosis following beta-interferon therapy for multiple myeloma.. PubMed. 12(2). 140–2.45 indexed citations
10.
Bobbio-Pallavicini, E, Camillo Porta, F Tacconi, et al.. (1995). Intravenous prostacyclin (as epoprostenol) infusion in thrombotic thrombocytopenic purpura. Four case reports and review of the literature. Italian Cooperative Group for Thrombotic Thrombocytopenic Purpura.. PubMed. 79(5). 429–37.13 indexed citations
Porta, Camillo, E Bobbio-Pallavicini, Riccardo Centurioni, & F Tacconi. (1993). Thrombotic thrombocytopenic purpura resistant to plasma-exchange: salvage treatment with high-dose IgG or vincristine. Italian Cooperative Group for TTP.. PubMed. 16 Suppl 5. 201–4.6 indexed citations
Pacchiarini, L, Federica Meloni, M Zucchella, et al.. (1992). Proaggregating and procoagulant activities of human mesothelioma tumor cells at different stages of "in vitro" culture.. PubMed. 76(5). 392–7.7 indexed citations
18.
Canevari, A, et al.. (1992). Antithrombin III biological activity and emotional stress in patients with coronary artery disease.. PubMed. 77(2). 180–2.20 indexed citations
19.
Grignani, Giovanni, M Zucchella, L Pacchiarini, et al.. (1991). Platelet activation by emotional stress in patients with coronary artery disease.. PubMed. 83(4 Suppl). II128–36.73 indexed citations
20.
Zucchella, M, Laura Dezza, L Pacchiarini, et al.. (1990). Human tumor cells cultured "in vitro" activate platelet function by producing ADP or thrombin.. PubMed. 74(6). 541–5.39 indexed citations
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive
bibliographic database. While OpenAlex provides broad and valuable coverage of the global
research landscape, it—like all bibliographic datasets—has inherent limitations. These include
incomplete records, variations in author disambiguation, differences in journal indexing, and
delays in data updates. As a result, some metrics and network relationships displayed in
Rankless may not fully capture the entirety of a scholar's output or impact.